PV·5: Difference between revisions
From Lexicon Leponticum
Jump to navigationJump to search
No edit summary |
No edit summary |
||
| Line 7: | Line 7: | ||
|word_number=5 | |word_number=5 | ||
|line_number=1 | |line_number=1 | ||
|script=Latin | |script=Latin script | ||
|object=PV·5 Zerbo | |object=PV·5 Zerbo | ||
|position=unknown | |position=unknown | ||
| Line 22: | Line 22: | ||
}} | }} | ||
==Commentary== | ==Commentary== | ||
*Epigraphische Datenbank Heidelberg [https://edh.ub.uni-heidelberg.de/edh/inschrift/HD017530 HD017530] | |||
*{{bib|CIL}} I<sup>2</sup> 3608 | |||
* {{bib|Tibiletti Bruno 1964}}: 183-196 (on the Lep. PN formation see esp. 195 and cited bibliography) | * {{bib|Tibiletti Bruno 1964}}: 183-196 (on the Lep. PN formation see esp. 195 and cited bibliography) | ||
* {{bib|Tibiletti Bruno 1978}}: 154 | * {{bib|Tibiletti Bruno 1978}}: 154 | ||
{{bibliography}} | {{bibliography}} | ||
Latest revision as of 16:43, 7 March 2023
| Inscription | |
|---|---|
| Reading in transliteration: | ueconirumelip(ondo)(lassum)sc(ripula)II |
| Reading in original script: | VECON IRUMELI P SC 
|
|
| |
| Object: | PV·5 Zerbo (cup) |
| Position: | unknown |
| Direction of writing: | dextroverse |
| Script: | Latin script |
| Number of letters: | 17 |
| Number of words: | 5 |
| Number of lines: | 1 |
| Workmanship: | unknown |
| Condition: | unknown |
|
| |
| Archaeological culture: | unknown [from object] |
| Date of inscription: | end of 2nd / beginning of 1st century BC [from object] |
|
| |
| Type: | mark of possessor |
| Language: | Latin |
| Syntactic analysis: | - |
| Meaning: | "of Veco Irumelius ..." |
|
| |
| Alternative sigla: | Morandi 2004: 105 |
|
| |
| Sources: | Morandi 2004: 593-594 |
Commentary
- Epigraphische Datenbank Heidelberg HD017530
- CIL I2 3608
- Tibiletti Bruno 1964: 183-196 (on the Lep. PN formation see esp. 195 and cited bibliography)
- Tibiletti Bruno 1978: 154
Bibliography
| CIL | Berlin-Brandenburg Academy of Sciences and Humanities, Corpus Inscriptionum Latinarum. (17 volumes, various supplements) |
|---|
